Brown Advisory’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-21,165
| Closed | -$1.69M | – | 1150 |
|
|
2021
Q1 | $1.69M | Sell |
21,165
-1,131
| -5% | -$88.3K | ﹤0.01% | 618 |
|
|
2020
Q4 | $1.76M | Sell |
22,296
-62,448
| -74% | -$3.66M | ﹤0.01% | 564 |
|
|
2020
Q3 | $3.72M | Buy |
84,744
+75
| +0.1% | +$3.69K | 0.01% | 437 |
|
|
2020
Q2 | $3.75M | Sell |
84,669
-1,150
| -1% | -$42.9K | 0.01% | 425 |
|
|
2020
Q1 | $3.08M | Sell |
85,819
-2,125
| -2% | -$121K | 0.01% | 419 |
|
|
2019
Q4 | $6.24M | Sell |
87,944
-265
| -0.3% | -$19.2K | 0.02% | 394 |
|
|
2019
Q3 | $6.6M | Sell |
88,209
-48
| -0.1% | -$4.07K | 0.02% | 371 |
|
|
2019
Q2 | $7.12M | Sell |
88,257
-27,378
| -24% | -$1.92M | 0.02% | 367 |
|
|
2019
Q1 | $7.74M | Sell |
115,635
-6,804
| -6% | -$515K | 0.02% | 393 |
|
|
2018
Q4 | $9.12M | Sell |
122,439
-1,239
| -1% | -$102K | 0.03% | 339 |
|
|
2018
Q3 | $11.4M | Sell |
123,678
-8,833
| -7% | -$841K | 0.03% | 317 |
|
|
2018
Q2 | $13M | Sell |
132,511
-322
| -0.2% | -$36K | 0.04% | 289 |
|
|
2018
Q1 | $14.8M | Sell |
132,833
-205
| -0.2% | -$23K | 0.05% | 261 |
|
|
2017
Q4 | $13.7M | Sell |
133,038
-974
| -0.7% | -$97K | 0.04% | 273 |
|
|
2017
Q3 | $12.6M | Buy |
134,012
+25
| +0% | +$1.97K | 0.04% | 272 |
|
|
2017
Q2 | $10.4M | Buy |
133,987
+250
| +0.2% | +$18.8K | 0.03% | 304 |
|
|
2017
Q1 | $10.7M | Buy |
133,737
+190
| +0.1% | +$15.1K | 0.04% | 282 |
|
|
2016
Q4 | $10.5M | Sell |
133,547
-905
| -0.7% | -$70.3K | 0.04% | 279 |
|
|
2016
Q3 | $10.5M | Sell |
134,452
-11,838
| -8% | -$859K | 0.04% | 280 |
|
|
2016
Q2 | $10.1M | Buy |
146,290
+42,000
| +40% | +$2.9M | 0.04% | 282 |
|
|
2016
Q1 | $7.44M | Buy |
104,290
+80,658
| +341% | +$5.06M | 0.03% | 308 |
|
|
2015
Q4 | $1.47M | Hold |
23,632
| – | – | 0.01% | 513 |
|
|
2015
Q3 | $1.34M | Buy |
+23,632
| New | +$1.25M | ﹤0.01% | 528 |
|
Brown Advisory's CMD Position: Q2 2021 in Review
Brown Advisory sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 21,165 shares — an estimated $1.69M sold.
Brown Advisory first reported a position in CMD in Q3 2015 and held it in 23 quarters. The position peaked at $14.8M in Q1 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Brown Advisory reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Brown Advisory sold 21,165 Cantel Medical Corporation shares in Q2 2021, an estimated $1.69M.
- Brown Advisory first reported a position in Cantel Medical Corporation in Q3 2015 and held it in 23 quarters.
- Brown Advisory's Cantel Medical Corporation position peaked at $14.8M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Brown Advisory's 13F filing for Q2 2021, filed 29 Jul 2021.